Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats

被引:0
|
作者
Ma∏gorzata Pietraszek
Krystyna Ossowska
机构
[1] Department of Neuro-Psychopharmacology,
[2] Institute of Pharmacology,undefined
[3] Polish Academy of Sciences,undefined
[4] 12 Sm´tna St.,undefined
[5] PL-31-343 Kraków,undefined
[6] Poland,undefined
关键词
Key words Prepulse inhibition; Phencyclidine; Chronic haloperidol; Antipsychotic action;
D O I
暂无
中图分类号
学科分类号
摘要
Prepulse inhibition is a model in which a weak subthreshold stimulus (prepulse), presented to an individual before a strong stimulus (pulse), inhibits a startle response to the latter. A deficit of prepulse inhibition induced by dopaminomimetics and antagonists of NMDA receptors has been suggested as an animal model of the sensorimotor deficit in schizophrenia. The aim of the present study was to examine the effect of chronic treatment with the classic neuroleptic haloperidol on the disruption of prepulse inhibition induced by the uncompetitive antagonist of NMDA receptors phencyclidine (PCP, 5mg/kg sc). Haloperidol in a dose of 1mg/kg/day was given to rats in drinking water for 3 months. The PCP-induced reduction in prepulse inhibition was not reversed by short-term (4-day) haloperidol administration. In contrast, long-term treatment with haloperidol (6 weeks or 3 months) diminished the PCP-induced effect. The present study suggests that the improvement in sensorimotor gating in the PCP model in rats by prolonged treatment with haloperidol may reflect its antipsychotic action.
引用
收藏
页码:466 / 471
页数:5
相关论文
共 50 条
  • [21] Effects of Sustained Phencyclidine Exposure on Sensorimotor Gating of Startle in Rats
    Zoë A Martinez
    Gaylord D Ellison
    Mark A Geyer
    Neal R Swerdlow
    Neuropsychopharmacology, 1999, 21 : 28 - 39
  • [22] Seroquel restores sensorimotor gating in phencyclidine-treated rats
    Swerdlow, NR
    Bakshi, V
    Geyer, MA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (03): : 1290 - 1299
  • [23] Differential effects of acute and subchronic clozapine and haloperidol on phencyclidine-induced decreases in voluntary sucrose consumption in rats
    Turgeon, Sarah M.
    Hulick, Virginia C.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2007, 86 (03) : 524 - 530
  • [24] Effect of acute and chronic olanzapine treatment on phencyclidine-induced behavioral sensitization in rats with neonatal dopamine loss
    Moy, SS
    Fernandes, A
    Qian, Y
    Rotella, DJ
    Kostrewa, RM
    Breese, GR
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 78 (01) : 47 - 56
  • [25] NEUROPHYSIOLOGICAL STUDIES OF SENSORY GATING IN RATS - EFFECTS OF AMPHETAMINE, PHENCYCLIDINE, AND HALOPERIDOL
    ADLER, LE
    ROSE, G
    FREEDMAN, R
    BIOLOGICAL PSYCHIATRY, 1986, 21 (8-9) : 787 - 798
  • [26] PROPRANOLOL ANTAGONIZES PHENCYCLIDINE-INDUCED HYPERACTIVITY AND STEREOTYPY IN RATS
    CONSROE, P
    BOREN, JL
    HSU, CH
    PHARMACOLOGY, 1982, 24 (02) : 96 - 104
  • [27] The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats
    Horiguchi, M.
    Huang, M.
    Meltzer, H. Y.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (02): : 605 - 614
  • [28] Synapsin II knockout mice show sensorimotor gating and behavioural abnormalities similar to those in the phencyclidine-induced preclinical animal model of schizophrenia
    Dyck, Bailee A.
    Skoblenick, Kevin J.
    Castellano, Jessica M.
    Ki, Kitty
    Thomas, Nancy
    Mishra, Ram K.
    SCHIZOPHRENIA RESEARCH, 2007, 97 (1-3) : 292 - 293
  • [29] No reversal of the phencyclidine-induced disruption of sensorimotor gating by the metabotropic glutamate receptor (mGluR) group II agonist, LY354740, in the rat
    Schreiber, R
    Dalmus, M
    Lowe, D
    De Vry, J
    NEUROPHARMACOLOGY, 1999, 38 (10) : A41 - A41
  • [30] Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats
    Hubbard, J. J.
    Laurenzana, E. M.
    Williams, D. K.
    Gentry, W. B.
    Owens, S. M.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (12) : 2181 - 2187